Keyphrases
Serum Biomarkers
100%
Population-based Cohort
100%
European Population
100%
Inflammatory Bowel Disease
100%
Genetic Markers
100%
Anti-Saccharomyces Cerevisiae
80%
Toll-like Receptor 4 (TLR4)
80%
CARD15
80%
MPO-ANCA
60%
Mutation Rate
40%
Healthy Controls
40%
Europe
40%
Population-based
20%
Etiology
20%
Genetic Heterogeneity
20%
Population Attributable Risk
20%
Patient Files
20%
North-South Divide
20%
Disease Behavior
20%
Scandinavian Countries
20%
Non-associated
20%
Patient-controlled
20%
North-south Gradient
20%
Disease Groups
20%
Asp299Gly
20%
Incident Cohort
20%
Antineutrophil Cytoplasmic Antibody
20%
Delayed Diagnosis
20%
Polymorphism
20%
Disease Location
20%
Genetic Factors
20%
Disease Phenotype
20%
South European
20%
Disease Susceptibility
20%
Complicated Disease
20%
Biochemistry, Genetics and Molecular Biology
TLR4
100%
Prevalence
100%
Genetics
100%
baker's yeast
100%
Mutation Rate
50%
Genetic Determinism
25%
Genetic Heterogeneity
25%
Immunology and Microbiology
Prevalence
100%
Inflammatory Bowel Disease
100%
TLR4
80%
baker's yeast
80%
Mutation Rate
40%
Neutrophil Cytoplasmic Antibody
20%
Heredity
20%
Genetic Heterogeneity
20%